Siemens Healthineers revenue and financials
€38.22Change from previous close: +0.39%Absolute change: +€0.15
In the fiscal year ended September 2025, Siemens Healthineers reported revenue of €23.38B (+4.53% year over year). Net income was €2.14B, a net margin of 9.2%.
Fiscal year ending in September. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +4.53%
- FY to Sep 2025 vs FY to Sep 2024
- Net income growth
- +10.40%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- 9.2%
- FY to Sep 2024: 8.7%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5,764 | 5,680 | 5,402 | 6,322 | 5,662 | 5,909 | 5,482 | 6,329 | 5,423 | 5,435 | 5,176 | 6,056 |
| Cost of revenue | 3,314 | 3,540 | 3,326 | 3,948 | 3,481 | 3,586 | 3,330 | 3,921 | 3,333 | 3,429 | 3,211 | 3,763 |
| Gross profit | 2,450 | 2,140 | 2,076 | 2,374 | 2,181 | 2,323 | 2,152 | 2,408 | 2,090 | 2,006 | 1,965 | 2,293 |
| Selling, general and administrative | 1,008 | 963 | 925 | 975 | 947 | 991 | 973 | 962 | 918 | 899 | 902 | 942 |
| Research and development | 488 | 487 | 476 | 499 | 493 | 485 | 481 | 496 | 484 | 474 | 464 | 486 |
| Operating income | 946 | 724 | 678 | 892 | 732 | 844 | 697 | 946 | 679 | 588 | 596 | 859 |
| EBIT | 946 | 724 | 678 | 892 | 732 | 844 | 697 | 946 | 679 | 588 | 596 | 859 |
| EBITDA | 1,251 | 1,024 | 976 | 1,201 | 1,102 | 1,156 | 1,002 | 959 | 973 | 916 | 887 | 951 |
| Interest expense | 103 | 100 | 96.0 | 108 | 104 | 104 | 108 | 142 | 116 | 111 | 107 | 102 |
| Pre-tax income | 877 | 644 | 602 | 770 | 736 | 730 | 616 | 844 | 595 | 542 | 542 | 774 |
| Income tax | 201 | 132 | 147 | 174 | 180 | 194 | 138 | 221 | 122 | 111 | 110 | 235 |
| Net income | 669 | 506 | 449 | 588 | 552 | 530 | 474 | 616 | 469 | 426 | 431 | 537 |
| Net income to common shareholders | 669 | 506 | 449 | 588 | 552 | 530 | 474 | 616 | 469 | 426 | 431 | 537 |
| Basic EPS | 0.60 | 0.45 | 0.40 | 0.53 | 0.49 | 0.47 | 0.42 | 0.55 | 0.42 | 0.38 | 0.39 | 0.48 |
| Diluted EPS | 0.60 | 0.45 | 0.40 | 0.52 | 0.49 | 0.47 | 0.42 | 0.55 | 0.42 | 0.38 | 0.38 | 0.48 |
| Average shares (basic) | 1,115 | 1,124 | 1,123 | 1,109 | 1,127 | 1,128 | 1,129 | 1,120 | 1,117 | 1,121 | 1,105 | 1,119 |
| Average shares (diluted) | 1,115 | 1,124 | 1,123 | 1,131 | 1,127 | 1,128 | 1,129 | 1,120 | 1,117 | 1,121 | 1,134 | 1,119 |
| Dividend per share | — | — | — | 1.00 | — | — | — | 0.95 | — | — | — | 0.95 |
